Dr. Praveen R. Arany

Dr. Praveen R. Arany

Associate Professor, Oral Biology & Biomedical Engineering

Dr. Praveen R. Arany is an Associate Professor with tenure in Oral Biology at the University at Buffalo School of Dental Medicine, with additional appointments in Surgery and Biomedical Engineering. Trained as a dentist and oral pathologist, he completed a joint PhD–residency program at Harvard University as a Harvard Presidential Scholar, followed by postdoctoral fellowships at institutions including the National Cancer Institute and the Harvard Wyss Institute.

Dr. Arany is a leading researcher in photobiomodulation and therapeutic laser applications, with over 150 scientific publications and more than 12,000 citations. His work focuses on the biological mechanisms by which light influences tissue repair, inflammation, and regeneration, contributing to evidence-based clinical protocols for laser use in medicine and dentistry.

He is the Executive Director of the World Association for Photobiomodulation Therapy and has held leadership roles in several international scientific organizations. His research and clinical insights support emerging applications of laser technology in diagnosis, prevention, and definitive treatment across dental and medical practice.

All Sessions by Dr. Praveen R. Arany

Oral Medicine and Radiology Pre-conference Track May 6, 2026
19:00 - 20:00

Emerging Applications of Lasers in Dental Medicine: From diagnostic accuracy to prevention and definitive treatment

Dental lasers have been around since the 1960s. However, their popularity has been limited by the expense and lack of understanding of their unique benefits. The American Dental Association (ADA) has formally recognized surgical applications of Lasers in Dentistry in their 2023 technical bulletin #133 that serves as a major milestone for the recognition of the field. Further, there has been tremendous progress with the non-surgical applications with specific recognition of Photobiomodulation (PBM). The US FDA has formally recognized PBM in 2024 and the ADA issues a key technical bulleting #189 on PBM. Most recently, PBM insurance codes have been approved to enable their routine clinic care. This talk will go over fundamental introduction to light and its interactions with biological tissue interactions that enables its surgical and non-surgical clinical applications. A major highlight will be to outline the use of PBM in supportive cancer care and recent advances in the mechanisms and dose enabling safe and effective clinical treatments